Ganga Pharmaceuticals Ltd is in the business of manufacturing & trading in Ayurvedic pharmaceuticals & allied productsBusiness Overview: Company does production of Ayurvedic Medicines by using techniques strictly as per Ancient text and Ayurved pharma companies. Apart from manufacturing, it is also into marketing and distribution of Bulk Ayurvedic Medicines...
Ganga Pharmaceuticals has announced that 7,00,000 warrants, previously issued at Rs. 14 each, were not exercised and converted into equity shares by the allottees within the stipulated 18-month period. Consequently, the initial 25% payment made on these warrants, amounting to Rs. 24.50 lakh (0.245 Cr), has been forfeited by the...
Ganga Pharmaceuticals' board has approved the allotment of 10.75 lakh new equity shares, each at an issue price of ₹14. These shares were issued following the conversion of warrants by both promoter and non-promoter investors, who paid the remaining 75% subscription amount. This move increases the company's total paid-up equity...
Ganga Pharmaceuticals Limited has confirmed that its Registrar and Share Transfer Agent, KFIN Technologies Limited, has completed the dematerialization and cancellation of share certificates during the quarter. The details of securities dematerialized and rematerialized have been duly reported to all stock exchanges where the company’s shares are listed. This ensures...
Ganga Pharmaceuticals Limited has announced a board meeting appointing Ms. Priti Bhaiya as Company Secretary and Compliance Officer, effective immediately. Ms. Bhaiya brings nine years of experience in secretarial compliance, legal, and administrative functions. She is an associate member of the Institute of Company Secretaries of India and is designated...
Ganga Pharmaceuticals has confirmed no deviation in the use of funds raised through its preferential issue of equity shares and convertible warrants totaling Rs. 1.71 crore. The company utilized Rs. 48.75 lakh for expanding manufacturing facilities, Rs. 81.25 lakh for working capital, and Rs. 40.62 lakh for general corporate purposes,...
